[Benefit of therapeutic drug monitoring of immunosuppressants and immunomodulators in the management of autoimmune diseases].
Rev Med Interne. 2022 Jul;43(7):412-418. doi: 10.1016/j.revmed.2022.03.343. Epub 2022 May 25.
Rev Med Interne. 2022.
PMID: 35643786
French.